Category: Workers Comp

529 posts found

FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

Millions of workers are changing occupations, leading to ripple effects for comp.

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.

The public comment period is underway for this action, which could help with safer drug disposal.

Healthe’s VP of Clinical Services will join a discussion on post-COVID lessons for workers’ comp.

VX-548 delivered significant improvements in pain with few adverse events.

Women workers were more adversely impacted by the pandemic and the recession.

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

Carriers share their thoughts on successful RTW programs.

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.

Proposed changes are open to public comment until April 11th.

After a drop in activity due to the pandemic, five states are now considering legislation.

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joined an educational webinar from IAIABC.

Prev 1 2 3 4 5 … 14 15 16 17 18 … 32 33 34 35 36 Next